Chromosomal alterations, point mutations and epigenetic silencing have been described to affect VHL function [5-7], while RASSF1A has frequently been detected to undergo promoter hypermethylation and epigenetic silencing in CC-RCC [8-11]. Here, VHL is linked to renal cell carcinoma.